Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Anne Bozon"'
Autor:
Walch, Agnès
Publikováno v:
Histoire, Économie et Société, 2001 Jan 01. 20(1), 123-124.
Externí odkaz:
https://www.jstor.org/stable/23613658
Autor:
Walch, Agnès
Publikováno v:
Histoire, Économie et Société, 2000 Oct 01. 19(4), 626-627.
Externí odkaz:
https://www.jstor.org/stable/23614903
Publikováno v:
Journal of Hepatology. 77:553-555
Autor:
Guillaume Le Cosquer, Romain Altwegg, Pauline Rivière, Barbara Bournet, Lucile Boivineau, Florian Poullenot, Anne Bozon, Louis Buscail, David Laharie, Cyrielle Gilletta
Publikováno v:
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
Anti-TNFα are recommended for preventing Crohn's disease (CD) postoperative recurrence (POR) in patients with risk factors. However, few data exploring anti-TNFα efficacy in patients with preoperative anti-TNFα failure are available so far.The aim
Autor:
Anne Bozon, Stéphane Nancey, Mélanie Serrero, Ludovic Caillo, Cyrielle Gilletta, Alban Benezech, Roman Combes, Guillaume Danan, Sandrine Akouete, Laurence Pages, Jean-François Bourgaux, Guillaume Le Cosquer, Lucile Boivineau, Magdalena Meszaros, Romain Altwegg
Publikováno v:
Clinics and Research in Hepatology and Gastroenterology. 47:102107
Autor:
Lieven Pouillon, Guillaume Bouguen, Bernard Flourié, Mathurin Fumery, Stephanie Viennot, Laurent Siproudhis, Franck Brazier, Jérôme Filippi, Pauline Veyrard, Florian Poullenot, Anthony Buisson, Lucile Boivineau, Xavier Treton, Momar Diouf, David Laharie, Cyrielle Gilletta, Stéphane Nancey, Romain Altwegg, Xavier Roblin, Anne Bozon, Laurent Peyrin-Biroulet
Publikováno v:
Journal of Crohn's and Colitis. 15:222-227
Background The approved maintenance regimens for ustekinumab in Crohn’s disease [CD] are 90 mg every 8 or 12 weeks. Some patients will respond partially to ustekinumab or will experience a secondary loss of response. It remains poorly known if thes
Autor:
Mathurin, Fumery, Laurent, Peyrin-Biroulet, Stephane, Nancey, Romain, Altwegg, Cyrielle, Gilletta, Pauline, Veyrard, Guillaume, Bouguen, Stephanie, Viennot, Florian, Poullenot, Jerome, Filippi, Anthony, Buisson, Anne, Bozon, Franck, Brazier, Lieven, Pouillon, Bernard, Flourie, Lucile, Boivineau, Laurent, Siproudhis, David, Laharie, Xavier, Roblin, Momar, Diouf, Xavier, Treton
Publikováno v:
Journal of Crohn's and Colitis
Journal of Crohn's and Colitis, 2021, 15 (2), pp.222-227. ⟨10.1093/ecco-jcc/jjaa177⟩
Journal of Crohn's and Colitis, Elsevier-Oxford University Press, 2021, 15 (2), pp.222-227. ⟨10.1093/ecco-jcc/jjaa177⟩
Journal of Crohn's and Colitis, 2021, 15 (2), pp.222-227. ⟨10.1093/ecco-jcc/jjaa177⟩
Journal of Crohn's and Colitis, Elsevier-Oxford University Press, 2021, 15 (2), pp.222-227. ⟨10.1093/ecco-jcc/jjaa177⟩
International audience; Introduction: The approved maintenance regimens for ustekinumab in Crohn's disease (CD) are 90 mg every 8 or 12 weeks. Some patients will partially respond to ustekinumab or will experience a secondary loss of response. It rem
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::8b0b2a0fa0dc81a79e014e5c3f29d52a
https://doi.org/10.1093/ecco-jcc/jjaa177
https://doi.org/10.1093/ecco-jcc/jjaa177
Autor:
Guillaume Jeantet, Guillaume Pineton de Chambrun, Benjamin Rivière, Natalie Funakoshi, Jeanne Ramos, Moglie Le Quintrec, Sylvie Delmas, Jean Emmanuel Serre, Gaspard Dufour, Jean-Christophe Valats, Michael Bismuth, Roman Combes, Pierre Blanc, Anne Bozon
Publikováno v:
World Journal of Gastroenterology
World Journal of Gastroenterology, Baishideng Publishing Group Co. Limited, 2017, 23 (48), pp.8660--8665. ⟨10.3748/wjg.v23.i48.8660⟩
World Journal of Gastroenterology, Baishideng Publishing Group Co. Limited, 2017, 23 (48), pp.8660--8665. ⟨10.3748/wjg.v23.i48.8660⟩
International audience; Cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) modifying agents have been involved in the development of intestinal inflammation, especially therapeutic monoclonal antibodies directed against CTLA-4. Here we report the a
Publikováno v:
Journal of Crohn's and Colitis. 14:1649-1649
Publikováno v:
Gastroenterology. 154(6)